Autolus Therapeutics (AUTL) Common Equity (2017 - 2026)
Autolus Therapeutics' Common Equity was $74.84 million in Q2 2026, down 78.4% from $346.46 million a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Common Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Autolus Therapeutics came in at $178.13 million, down 58.3% from FY2024.
- Common Equity shows a five-year compound annual growth rate of -3.2% (FY2020 to FY2025).
- In earlier years, Common Equity was $427.33 million in FY2024 (+283.3%), $111.47 million in FY2023 (-62.7%), $298.67 million in FY2022 (-4.7%) and $313.32 million in FY2021 (+49.2%).
- The Q2 2026 figure marks the lowest quarterly Common Equity in data going back to Q4 2017.
- Compared with a year earlier, Common Equity was higher in two of the last seven quarters, with growth averaging 28.0%.
- The best year-over-year quarter for Common Equity over five years was Q4 2024 (growth of 283.3%); the worst was Q2 2026 (a decline of 78.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Autolus Therapeutics | 660.38 Mn | -663.71 Mn | 25.22 Mn | 74.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74.84 Mn |
| Dec 31, 2025 | 178.13 Mn |
| Sep 30, 2025 | 265.45 Mn |
| Jun 30, 2025 | 346.46 Mn |
| Mar 31, 2025 | 371.11 Mn |
| Dec 31, 2024 | 427.33 Mn |
| Sep 30, 2024 | 476.97 Mn |
| Jun 30, 2024 | 527.84 Mn |
| Mar 31, 2024 | 582.03 Mn |
| Dec 31, 2023 | 111.47 Mn |
| Sep 30, 2023 | 180.52 Mn |
| Jun 30, 2023 | 229.34 Mn |
| Mar 31, 2023 | 266.92 Mn |
| Dec 31, 2022 | 298.67 Mn |
| Sep 30, 2022 | 161.15 Mn |
| Jun 30, 2022 | 214.52 Mn |
| Mar 31, 2022 | 271.14 Mn |
| Dec 31, 2021 | 313.32 Mn |
| Sep 30, 2021 | 244.73 Mn |
| Jun 30, 2021 | 283.68 Mn |
API Access
Autolus Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();